Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and Barinthus Biotherapeutics (BRNS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on US Physical Therapy (USPH – Research Report) and Barinthus Biotherapeutics (BRNS – Research Report).
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
US Physical Therapy (USPH)
In a report released today, Ryan Daniels from William Blair reiterated a Hold rating on US Physical Therapy. The company's shares closed last Wednesday at $70.96.
According to TipRanks.com, Daniels is a 4-star analyst with an average return of 7.7% and a 49.6% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, Lifestance Health Group, and Pediatrix Medical Group.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for US Physical Therapy with a $108.25 average price target.
Barinthus Biotherapeutics (BRNS)
In a report released today, Andy Hsieh from William Blair reiterated a Buy rating on Barinthus Biotherapeutics. The company's shares closed last Wednesday at $0.99, close to its 52-week low of $0.80.
According to TipRanks.com, Hsieh is a 4-star analyst with an average return of 6.0% and a 43.7% success rate. Hsieh covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Corbus Pharmaceuticals, and Terns Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Barinthus Biotherapeutics with a $4.50 average price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Archer Aviation Stock (ACHR) Soars on Strong Q1 and Upcoming UAE Launch
Archer Aviation (ACHR) has seen its stock jump over 47% this week since it delivered a commanding performance in the first quarter of 2025, beating earnings expectations while positioning itself for the historic milestone of becoming one of the first companies to launch commercial electric air taxi operations with its eVTOL aircraft. The results showcase a company successfully navigating the complex path from aviation startup to operational reality. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter The future of flying cars is finally here. I have been, and continue to be, extremely bullish on this opportunity. While ACHR stock is approaching its all-time high, the sky is literally the limit for this nascent technology. The company's Q1 2025 financial results exceeded Wall Street's expectations across key metrics. As a startup, the company has been in cash-burning mode for some time, yet for the quarter, Archer's net loss improved dramatically by falling 20% year-over-year to $93.4 million from $116.5 million in Q1 2024. This beat demonstrates the company's improving cost management as it approaches commercialization. Still, the company ended the quarter with $1 billion in cash and cash equivalents. This war chest increased by $196 million from year-end 2024, thanks to successful capital raises that gave the company a substantial financial runway to launch its first aircraft later this year. Archer reported an earnings per share loss of just $0.17, significantly better than analyst estimates ranging from $0.22 to $0.28 per share. Looking ahead, management projects a Q2 adjusted EBITDA loss between $100 million and $120 million, reflecting continued strategic investments in manufacturing, certification, and international expansion. Archer has moved beyond the drawing board and into serious production mode. The company began manufacturing conforming Midnight aircraft as planned, targeting up to 10 units in 2025. By year-end, Archer aims to produce two aircraft per month, as it ramps to a pace supporting meaningful commercial operations. The company has also made strategic acquisitions to strengthen its manufacturing capabilities, including a composites manufacturing facility, in a move to control key aspects of its supply chain while still leveraging established aerospace suppliers for other components. This hybrid approach differentiates Archer from competitors like Joby Aviation (JOBY), which has pursued a more vertically integrated strategy. Archer's decision to work with proven Tier 1 aerospace suppliers is intended to reduce risk and accelerate time to market. Archer has assembled an impressive group of strategic partners, such as its collaboration with Palantir Technologies (PLTR). The partnership with the technology company aims to develop next-gen artificial intelligence systems for aviation. Its partnership with United Airlines (UAL) represents a significant opportunity in the lucrative U.S. market, with plans for an air taxi network connecting Manhattan to major airports. Meanwhile, the exclusive partnership with Anduril Industries opens defense market opportunities, including hybrid VTOL aircraft for military applications. Defense contracts could accelerate cash generation as they don't require the same FAA certification process as commercial aircraft. A significant milestone for Archer remains its imminent commercial launch in the United Arab Emirates. The first piloted Midnight aircraft is expected to be delivered to the UAE this summer, with commercial passenger flights beginning by the fourth quarter of 2025. The company's 'Launch Edition' program represents a carefully crafted strategy for entering international markets with local partners who understand regional dynamics. For example, Abu Dhabi Aviation will serve as Archer's first commercial customer, with Ethiopian Airlines lined up to follow shortly thereafter. This approach allows Archer to provide comprehensive support, including aircraft, pilots, technicians, and software, while building operational expertise in real-world conditions. Beyond the UAE, Archer is actively pursuing opportunities across multiple continents. The company has identified partnerships and potential operations in India, Japan, Singapore, Australia, Saudi Arabia, and South Korea. A recent agreement with Korea's KakaoMobility targets commercial operations in South Korea by 2026. Despite the positive momentum, Archer faces significant challenges that are common to the eVTOL industry. The most critical requirement remains FAA Type Certification for its Midnight aircraft. While Archer has secured important certifications like Part 135 for air carrier operations, full type certification remains pending and could influence commercial launch timelines in the U.S. Further, competition is intensifying. Well-funded rivals like Joby Aviation are racing to capture similar markets, and early commercial success will likely depend on execution, timing, and the ability to scale operations efficiently. Archer Aviation is rated a Strong Buy based on the most recent recommendations of seven analysts (6 Buy, 1 Hold). The average 12-month price target for ACHR stock is $12.83, representing a ~5% downside from current levels. Despite the downside price targets, most analysts remain bullish about Archer's prospects post earnings. For instance, Cantor Fitzgerald analyst Andres Sheppard maintains a bullish stance with a $13 price target, citing the company's strong position in advanced air mobility and valuable partnerships. Needham's Chris Pierce and H.C. Wainwright's Amit Dayal both maintain Buy ratings with price targets of $13 and $12.50, respectively. They cite Archer's diversified approach, combining civil and defense markets, and its substantial cash position, which provides flexibility during the critical commercialization phase. We're witnessing a pivotal moment in aviation history, and Archer is emerging as a frontrunner. With a solid financial foundation, rapidly advancing manufacturing capabilities, and commercial operations just around the corner, the company is well-positioned to spearhead the eVTOL movement. Its upcoming launch in the UAE will be a critical milestone—one that could prove not only the Midnight aircraft's technical readiness but also the broader operational and economic case for eVTOLs. A successful rollout could open the door to global expansion and reinforce confidence in the market's long-term potential. I remain bullish on Archer's outlook. Its leadership position makes it an attractive opportunity for investors seeking exposure to the fast-developing urban air mobility space. Disclaimer & DisclosureReport an Issue Sign in to access your portfolio
Business Insider
2 hours ago
- Business Insider
Barclays Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Barclays analyst Richard Taylor maintained a Hold rating on Dr. Martens Plc (DOCS – Research Report) today and set a price target of £0.90. The company's shares closed last Friday at p81.95. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Taylor is a 4-star analyst with an average return of 6.3% and a 50.99% success rate. Taylor covers the Consumer Cyclical sector, focusing on stocks such as WH Smith, Pets at Home, and JD Sports Fashion. Dr. Martens Plc has an analyst consensus of Hold, with a price target consensus of p71.50, representing a -12.75% downside. In a report released on June 5, Morgan Stanley also maintained a Hold rating on the stock with a p70.00 price target. DOCS market cap is currently £790.6M and has a P/E ratio of 174.36. Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DOCS in relation to earlier this year.
Business Insider
2 hours ago
- Business Insider
Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)
Barclays analyst Pravin Gondhale maintained a Hold rating on PLUXEE N.V. (PLX – Research Report) today and set a price target of €26.00. The company's shares closed last Friday at €20.10. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Gondhale is a 2-star analyst with an average return of 1.6% and a 48.57% success rate. PLUXEE N.V. has an analyst consensus of Moderate Buy, with a price target consensus of €27.77. PLX market cap is currently €4.2B and has a P/E ratio of 17.88.
